Your browser doesn't support javascript.
loading
ORC6 acts as a biomarker and reflects poor outcome in clear cell renal cell carcinoma.
Pan, Qiufeng; Li, Fuchun; Ding, Yi; Huang, Haoxuan; Guo, Ju.
Afiliación
  • Pan Q; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Li F; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Ding Y; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Huang H; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Guo J; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
J Cancer ; 13(8): 2504-2514, 2022.
Article en En | MEDLINE | ID: mdl-35711825
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Cancer Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Cancer Año: 2022 Tipo del documento: Article País de afiliación: China